tiprankstipranks
Trending News
More News >
KalVista Pharmaceuticals (KALV)
NASDAQ:KALV
US Market
Advertisement

KalVista Pharmaceuticals (KALV) Financial Statements

Compare
560 Followers

KalVista Pharmaceuticals Financial Overview

KalVista Pharmaceuticals's market cap is currently $598.70M. The company's EPS TTM is $-1.12; its P/E ratio is ―; KalVista Pharmaceuticals is scheduled to report earnings on September 11, 2025, and the estimated EPS forecast is $-1.00. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Currency in USD

KalVista Pharmaceuticals Earnings and Revenue History

KalVista Pharmaceuticals Debt to Assets

KalVista Pharmaceuticals Cash Flow

KalVista Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis